Global Needle-free Injection Systems Market Growth 2021-2026

Global Needle-free Injection Systems Market Growth 2021-2026

According to this latest study, the 2021 growth of Needle-free Injection Systems will have significant change from previous year. By the most conservative estimates of global Needle-free Injection Systems market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 172.2 million in 2020. Over the next five years the Needle-free Injection Systems market will register a 5.3% CAGR in terms of revenue, the global market size will reach US$ 211.6 million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Needle-free Injection Systems market by product type, application, key manufacturers and key regions and countries. Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7. Reusable Injector Single-use Injector Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8. Vaccine Delivery Insulin Delivery Others This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8. Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3. Antares Pharma Endo International plc Inovio Pharmaceuticals Injex Pharma National Medical Products Inc (J-Tip) Recipharm European Pharma Group (InsuJet) Miracle Medical Medical International Technology (MIT) Akra Dermojet PharmaJet Portal Instruments Crossject Medical Technology MIKA MEDICAL Ferring Pharmaceuticals D'Antonio Consultants International Lepu Medical TECHiJET